ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 181 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $265,000 | -46.8% | 5,110 | -48.4% | 0.00% | -50.0% |
| Q2 2020 | $498,000 | +4.2% | 9,911 | +24.7% | 0.00% | +33.3% |
| Q3 2019 | $478,000 | +113.4% | 7,950 | +200.0% | 0.00% | +200.0% |
| Q2 2019 | $224,000 | +1.8% | 2,650 | -14.5% | 0.00% | 0.0% |
| Q4 2018 | $220,000 | -40.1% | 3,100 | -27.9% | 0.00% | -50.0% |
| Q3 2018 | $367,000 | +35.9% | 4,300 | -18.9% | 0.00% | 0.0% |
| Q4 2014 | $270,000 | -28.2% | 5,300 | -44.2% | 0.00% | -33.3% |
| Q3 2014 | $376,000 | -14.7% | 9,500 | -5.0% | 0.00% | 0.0% |
| Q1 2014 | $441,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 1,055,719 | $35,367,000 | 12.68% |
| GREAT POINT PARTNERS LLC | 828,253 | $27,746,000 | 5.70% |
| McClain Value Management LLC | 116,153 | $3,891,000 | 4.80% |
| Stonepine Capital Management, LLC | 231,913 | $7,769,000 | 4.63% |
| ARMISTICE CAPITAL, LLC | 228,000 | $7,638,000 | 1.81% |
| Opaleye Management Inc. | 90,000 | $3,015,000 | 1.78% |
| Matarin Capital Management, LLC | 257,268 | $8,618,478,000 | 0.97% |
| HAYS ADVISORY LLC | 116,939 | $3,917,000 | 0.87% |
| Granahan Investment Management | 496,025 | $16,617,000 | 0.57% |
| AlphaMark Advisors, LLC | 33,000 | $1,106,000 | 0.57% |